Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P) - A Multicentre Retrospective Analysis in the European Prostate Cancer Centres of Excellence for Prostate Cancer (EPCCE)

NCT07455097 is registered in ClinicalTrials.gov with Heinrich-Heine University, Duesseldorf as lead sponsor.

NCT NCT07455097
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07455097 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COMBINED PSMA-PET/CT AND MRI STAGING IN INTERMEDIATE AND HIGH-RISK PATIENTS PROSTATA-CANCER (COMBINE-P) - A Multicentre Retrospective Analysis in the European Prostate Cancer Centres of Excellence for Prostate Cancer (EPCCE)
Lead sponsor
Heinrich-Heine University, Duesseldorf
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2026
Completion date
December 31, 2026
Enrollment
600 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk prostate cancer, intermediate-risk prostate cancer